Trial intelligence / Profile preview

Vonoprazan vs Esomeprazole or Rabeprazole in Healthy Men

NCT02037477Phase 3Completed

Sponsor
Takeda
Start
Jan 2014
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of vonoprazan in acid peptic disorder (APD), sponsored by Takeda. Started Jan 2014; status: completed.

02

Drugs

vonoprazan
03

Conditions

acid peptic disorder (APD)

Beyond the preview

Go deeper on NCT02037477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02037477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call